Kala Pharmaceuticals
Price & Volume
Stats
See more52W Range | $4.21-$10.97 |
Market Cap | $31.3M |
Shares Short | 37,467 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $1.3M |
Diluted EPS | -$11.67 |
News
See moreYahoo Finance • last year
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Yahoo Finance • last year
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last year
KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference
Yahoo Finance • last year
Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. Mark T. Iwicki |
CFO | Ms. Mary Reumuth CPA |
Address | 1167 Massachusetts Avenue, Arlington, MA, United States, 02476 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 43 |
